Profilo
Mr. Stuart Knight is a Chief Information Officer & Senior Vice President at Theravance Biopharma, Inc. Mr. Knight was previously employed as a Head-Global Markets IT & Infrastructure by Galderma Pharma SA and a Vice President-Information Technology by Ipsen Biopharmaceuticals, Inc. He received his undergraduate degree from London South Bank University.
Posizioni attive di Stuart Knight
| Società | Posizione | Inizio |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2014 |
Precedenti posizioni note di Stuart Knight
| Società | Posizione | Fine |
|---|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Direttore Tecnico/Scientifico/R&S | 01/10/2014 |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
Formazione di Stuart Knight
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Health Technology |
London South Bank University
London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
















